Form 8-K - Current report:
SEC Accession No. 0001493152-25-005633
Filing Date
2025-02-10
Accepted
2025-02-10 16:05:32
Documents
13
Period of Report
2025-02-04
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37803
  Complete submission text file 0001493152-25-005633.txt   214272

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE pcsa-20250204.xsd EX-101.SCH 3060
3 XBRL LABEL FILE pcsa-20250204_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE pcsa-20250204_pre.xml EX-101.PRE 24195
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3687
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 25605769
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)